{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:palsucibep pegol [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:precemtabart tocentecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:besufetamig [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:beludavimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:bebtelovimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:opelkibart elmanitin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ciltistotug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:olintatug tesirine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN